Heart-related diseases are a major cause of many deaths. People with high cholesterol or body fat are at higher risk to get a heart attack. As heart attack is a common and leading cause of death, hence it is important to find the proper treatment that can slow down the risk for people. A new cholesterol drug that is used with strain medicines is found effective to slow down the heart attack risk.
A study of heart attack survivors gives way to this approach that is calling to be beneficial for many. These results about Praluent is announced on Saturday at an American College of Cardiology conference in Florida. This is for the first time when a cholesterol drug works effectively to reduce the death rate since statins. The study leader Dr. Philippe Gabriel Steg from Hospital Bichat in Paris says,”It’s the ultimate outcome; it’s what matters to patients.”
But the benefits are found to be very small. One of the health expert Dr. Amit Khera who is a preventive cardiologist at UT Southwestern Medical Center in Dallas says,”That’s a high cost.” He is also a spokesman for the American Heart Association. The drug maker from Sanofi and Regeneron Pharmaceuticals who are also the sponsor of the study tells that they are working to ensure the prices to serve the medicines to those who need it the most.
Dr. Jeffrey Kuvin who is the conference leader and cardiology chief at Dartmouth-Hitchcock Medical Center tell,”We need to reset our expectations.” He also tells that there is a need to realize the benefits of a new drug that actually has a less effect when gets added to good treatments such as statins. Another health expert Duke University cardiologist Dr. Christopher Granger says that he had been unconvinced with the update made about the positive effects of this drug.